| Design and validation of a histological scoring system for nonalcoholic fatty liver disease DE Kleiner, EM Brunt, M Van Natta, C Behling, MJ Contos, OW Cummings, ... Hepatology 41 (6), 1313-1321, 2005 | 10990 | 2005 |
| Prevalence of fatty liver in children and adolescents JB Schwimmer, R Deutsch, T Kahen, JE Lavine, C Stanley, C Behling Pediatrics 118 (4), 1388-1393, 2006 | 1796 | 2006 |
| Histopathology of pediatric nonalcoholic fatty liver disease JB Schwimmer, C Behling, R Newbury, R Deutsch, C Nievergelt, ... Hepatology 42 (3), 641-649, 2005 | 938 | 2005 |
| Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer JB Welsh, PP Zarrinkar, LM Sapinoso, SG Kern, CA Behling, BJ Monk, ... Proceedings of the National Academy of Sciences 98 (3), 1176-1181, 2001 | 883 | 2001 |
| Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease K De Hepatology 41, 1313-1321, 2005 | 844 | 2005 |
| Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease JB Schwimmer, R Deutsch, JB Rauch, C Behling, R Newbury, JE Lavine The Journal of pediatrics 143 (4), 500-505, 2003 | 718 | 2003 |
| Prospective study of outcomes in adults with nonalcoholic fatty liver disease AJ Sanyal, ML Van Natta, J Clark, BA Neuschwander-Tetri, AM Diehl, ... New England Journal of Medicine 385 (17), 1559-1569, 2021 | 639 | 2021 |
| Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer JM Carethers, EJ Smith, CA Behling, L Nguyen, A Tajima, RT Doctolero, ... Gastroenterology 126 (2), 394-401, 2004 | 531 | 2004 |
| Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study R Loomba, T Wolfson, B Ang, J Hooker, C Behling, M Peterson, ... Hepatology 60 (6), 1920-1928, 2014 | 527 | 2014 |
| The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients HM Patton, K Patel, C Behling, D Bylund, LM Blatt, M Vallée, S Heaton, ... Journal of hepatology 40 (3), 484-490, 2004 | 480 | 2004 |
| Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD—clinicopathologic correlations from the nonalcoholic … EM Brunt, DE Kleiner, LA Wilson, A Unalp, CE Behling, JE Lavine, ... Hepatology 49 (3), 809-820, 2009 | 413 | 2009 |
| Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection A Pohl, C Behling, D Oliver, M Kilani, P Monson, T Hassanein Official journal of the American College of Gastroenterology| ACG 96 (11 …, 2001 | 390 | 2001 |
| Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research HM Patton, C Sirlin, C Behling, M Middleton, JB Schwimmer, JE Lavine Journal of pediatric gastroenterology and nutrition 43 (4), 413-427, 2006 | 354 | 2006 |
| Association of histologic disease activity with progression of nonalcoholic fatty liver disease DE Kleiner, EM Brunt, LA Wilson, C Behling, C Guy, M Contos, ... JAMA network open 2 (10), e1912565-e1912565, 2019 | 308 | 2019 |
| Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease JB Schwimmer, JS Johnson, JE Angeles, C Behling, PH Belt, I Borecki, ... Gastroenterology 157 (4), 1109-1122, 2019 | 248 | 2019 |
| Liver Fibrosis: Noninvasive Diagnosis with Double Contrast Material–enhanced MR Imaging1 DA Aguirre, CA Behling, E Alpert, TI Hassanein, CB Sirlin Radiology 239 (2), 425-437, 2006 | 244 | 2006 |
| Prevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease KP Newton, J Hou, NA Crimmins, JE Lavine, SE Barlow, SA Xanthakos, ... JAMA pediatrics 170 (10), e161971-e161971, 2016 | 230 | 2016 |
| Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens JT Lonergan, C Behling, H Pfander, TI Hassanein, WC Mathews Clinical infectious diseases 31 (1), 162-166, 2000 | 225 | 2000 |
| Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial SA Harrison, PJ Ruane, BL Freilich, G Neff, R Patil, CA Behling, C Hu, ... Nature medicine 27 (7), 1262-1271, 2021 | 224 | 2021 |
| Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage MS Siddiqui, G Yamada, R Vuppalanchi, M Van Natta, R Loomba, C Guy, ... Clinical gastroenterology and hepatology 17 (9), 1877-1885. e5, 2019 | 217 | 2019 |
